Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoembolization in HCC or Neuroendocrine Hepatic Metastases
NCT00003907Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 1999
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin, mitomycin c in hepatocellular carcinoma (HCC), Neuroendocrine Neoplasm (NEN), sponsored by Eastern Cooperative Oncology Group. Started Dec 1999; status: completed.
02
Drugs
cisplatindoxorubicinmitomycin c
03
Conditions
hepatocellular carcinoma (HCC)Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT00003907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003907.